"Immunocompromised Host" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A human or animal whose immunologic mechanism is deficient because of an immunodeficiency disorder or other disease or as the result of the administration of immunosuppressive drugs or radiation.
Descriptor ID |
D016867
|
MeSH Number(s) |
G12.470
|
Concept/Terms |
Immunocompromised Host- Immunocompromised Host
- Host, Immunocompromised
- Hosts, Immunocompromised
- Immunocompromised Hosts
- Immunocompromised Patient
- Immunocompromised Patients
- Patient, Immunocompromised
- Patients, Immunocompromised
- Immunosuppressed Host
- Host, Immunosuppressed
- Hosts, Immunosuppressed
- Immunosuppressed Hosts
|
Below are MeSH descriptors whose meaning is more general than "Immunocompromised Host".
Below are MeSH descriptors whose meaning is more specific than "Immunocompromised Host".
This graph shows the total number of publications written about "Immunocompromised Host" by people in this website by year, and whether "Immunocompromised Host" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 0 | 3 | 3 |
1996 | 0 | 1 | 1 |
1997 | 0 | 2 | 2 |
1998 | 1 | 2 | 3 |
1999 | 1 | 2 | 3 |
2000 | 1 | 1 | 2 |
2001 | 1 | 0 | 1 |
2002 | 1 | 0 | 1 |
2003 | 1 | 1 | 2 |
2004 | 2 | 3 | 5 |
2005 | 0 | 3 | 3 |
2006 | 2 | 4 | 6 |
2007 | 1 | 3 | 4 |
2008 | 0 | 3 | 3 |
2009 | 1 | 2 | 3 |
2010 | 1 | 1 | 2 |
2011 | 1 | 1 | 2 |
2012 | 1 | 0 | 1 |
2013 | 4 | 1 | 5 |
2014 | 3 | 2 | 5 |
2015 | 3 | 3 | 6 |
2016 | 3 | 2 | 5 |
2017 | 0 | 6 | 6 |
2018 | 1 | 4 | 5 |
2019 | 3 | 4 | 7 |
2020 | 1 | 8 | 9 |
2021 | 1 | 4 | 5 |
2023 | 1 | 2 | 3 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunocompromised Host" by people in Profiles.
-
Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient. Virol J. 2023 10 27; 20(1):246.
-
Infectious complications of car T-cell therapy: A longitudinal risk model. Transpl Infect Dis. 2023 Nov; 25 Suppl 1:e14148.
-
Treatment options for severe or refractory mpox virus infection in patients with advanced HIV. Int J STD AIDS. 2023 05; 34(6):366-373.
-
Management of Pulmonary Mucormycosis After Orthotopic Heart Transplant: A Case Series. Transplant Proc. 2021 Dec; 53(10):3051-3055.
-
Gastrointestinal Surgical Emergencies in the Neutropenic Immunocompromised Patient. J Gastrointest Surg. 2021 12; 25(12):3258-3264.
-
Geotrichum infection in an immunocompetent host with SARS-CoV-2 infection. Tuberk Toraks. 2021 Sep; 69(3):421-424.
-
COVID-19 reinfection: a rapid systematic review of case reports and case series. J Investig Med. 2021 08; 69(6):1253-1255.
-
Cancer, transplant, and immunocompromising conditions were not significantly associated with severe illness or death in hospitalized COVID-19 patients. J Clin Virol. 2021 07; 140:104850.
-
Cording in Disseminated Mycobacterium chelonae Infection in an Immunocompromised Patient. Lab Med. 2021 May 04; 52(3):e50-e52.
-
Bilateral pleural masses in an immunocompromised patient. BMJ Case Rep. 2020 Nov 04; 13(11).